Hydroxyhexamide

CAS No. 3168-01-2

Hydroxyhexamide( (±)-Hydroxyhexamid )

Catalog No. M17724 CAS No. 3168-01-2

Hydroxyhexamide is a pharmacologically active metabolite of Acetohexamide, used as a hypoglycemic agent.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 81 In Stock
5MG 133 In Stock
10MG 237 In Stock
25MG 402 In Stock
50MG 581 In Stock
100MG 799 In Stock
500MG 1611 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Hydroxyhexamide
  • Note
    Research use only, not for human use.
  • Brief Description
    Hydroxyhexamide is a pharmacologically active metabolite of Acetohexamide, used as a hypoglycemic agent.
  • Description
    Hydroxyhexamide is a pharmacologically active metabolite of Acetohexamide, used as a hypoglycemic agent.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    (±)-Hydroxyhexamid
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    PPAR
  • Recptor
    ATP-sensitive potassium (KATP) channels
  • Research Area
    Cardiovascular Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    3168-01-2
  • Formula Weight
    326.41
  • Molecular Formula
    C15H22N2O4S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : ≥ 300 mg/mL; 919.09 mM
  • SMILES
    O=C(NC1CCCCC1)NS(=O)(=O)c2ccc(cc2)C(C)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Imamura Y,etal.Hypoglycemic effect of S(-)-hydroxyhexamide, a major metabolite of acetohexamide, and its enantiomer R(+)-hydroxyhexamide.Life Sci. 2001 Sep 7;69(16):1947-55.
molnova catalog
related products
  • Indeglitazar

    Indeglitazar is orally available pan-agonist of PPAR (PPAR subtypes alpha (α), delta (δ), and gamma (γ)).

  • Oroxin A (b)

    Oroxin A is a partial PPARγ agonist that can activate PPARγ transcriptional activation in vitro and in vivo. Oroxin A also exhibited inhibitory activity against α-glucosidase and antioxidant capacity.

  • Growth hormone relea...

    Growth hormone releasing peptide ia a natual product and has anti-inflammatory effects due to its inhibitory effect on PKC-induced activation of p38 JNK and NF-κB possibly by targeting to MKP-1 and PP2A.